GLP-1 drugs, compared head-to-head
Ozempic, Wegovy, Mounjaro, Zepbound — same drug or different? Which is dosed for weight loss? Here are the exact head-to-head comparisons, each on one normalized table: molecule, mechanism, FDA-approved use, and what the pivotal trials actually showed. A clinician chooses the drug and dose; this is general information.
By the pharmaranks editorial teamReviewed against FDA prescribing information (DailyMed) + pivotal trials (PubMed) sourcesHow we research
- Wegovy vs OzempicSame molecule, different brand & dose
- Mounjaro vs OzempicDifferent molecules — how they compare
- Zepbound vs WegovyDifferent molecules — how they compare
- Zepbound vs MounjaroSame molecule, different brand & dose
- Rybelsus vs OzempicSame molecule, different brand & dose
- Mounjaro vs WegovyDifferent molecules — how they compare
General information, not medical advice. Efficacy figures are pivotal-trial averages — individual results, side effects, and cost vary. Only a licensed clinician can choose, start, switch, or dose these medicines.